Stocks and Investing
Stocks and Investing
Mon, April 18, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Connor Lynagh Maintained (XYL) at Buy with Decreased Target to $110 on, Apr 18th, 2022
Connor Lynagh of Morgan Stanley, Maintained "Xylem Inc." (XYL) at Buy with Decreased Target from $120 to $110 on, Apr 18th, 2022.
Connor has made no other calls on XYL in the last 4 months.
There are 3 other peers that have a rating on XYL. Out of the 3 peers that are also analyzing XYL, 1 agrees with Connor's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Pavel Molchanov of "Raymond James" Upgraded from Sell to Hold on, Tuesday, April 5th, 2022
These are the ratings of the 2 analyists that currently disagree with Connor
- Deane Dray of "RBC Capital" Maintained at Buy with Decreased Target to $124 on, Friday, February 4th, 2022
- John Walsh of "Credit Suisse" Maintained at Sell with Decreased Target to $98 on, Friday, February 4th, 2022
Contributing Sources